Renal denervation in the management of hypertension

Area of Science:

• Cardiology
• Nephrology
• Interventional Cardiology

Background:

• Arterial hypertension is a major global health issue, leading to significant cardiovascular, cerebrovascular, and renal disease.
• Despite effective pharmacotherapy, blood pressure (BP) control remains suboptimal, contributing to rising mortality rates.
• Poor adherence and persistence with daily medications present challenges in managing hypertension.

Purpose of the Study:

• To summarize the rationale and evidence for catheter-based renal denervation (RDN) as a device-based therapy for hypertension.
• To provide recommendations for safe RDN procedures.
• To discuss the current role and clinical practice of RDN in hypertension management.

Main Methods:

• Review of existing literature and clinical trial data on renal denervation.
• Analysis of the safety and efficacy of RDN procedures.
• Examination of current clinical guidelines and practical applications of RDN.

Main Results:

• Renal denervation has been extensively studied as a device-based approach to overcome pharmacotherapy limitations.
• Evidence suggests RDN can be a safe and effective adjunctive therapy for specific hypertensive patients.
• Guidelines and clinical practice are evolving to incorporate RDN into comprehensive hypertension management strategies.

Conclusions:

• Renal denervation presents a promising therapeutic option for patients with resistant hypertension or medication non-adherence.
• Adherence to procedural recommendations is crucial for ensuring the safety and efficacy of RDN.
• Further research and guideline refinement will clarify the optimal role of RDN in the evolving landscape of hypertension treatment.